Whitehawk Therapeutics In...

NASDAQ: WHWK · Real-Time Price · USD
1.60
-0.02 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
1.60
0.00%
After-hours: Aug 15, 2025, 04:04 PM EDT

Whitehawk Therapeutics Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
25.98M 24.35M 15.22M 1.12M
Cost of Revenue
54.05M 51.74M 34M 19.67M
Gross Profit
-28.07M -27.38M -18.78M -18.55M
Operating Income
-67.46M -71.93M -62.68M -111.22M
Interest Income
3.92M 6.4M 2.4M 13K
Pretax Income
-63.69M -65.77M -60.51M -110.09M
Net Income
-63.69M -65.77M -60.51M -110.09M
Selling & General & Admin
36.75M 44.55M 40.18M 18.51M
Research & Development
51.03M 48.93M 32.66M 19.67M
Other Expenses
-48.39M -48.93M -28.94M 54.49M
Operating Expenses
39.39M 44.55M 43.9M 92.67M
Interest Expense
154K 231K 230K 665K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
93.44M 96.29M 77.9M 112.34M
Income Tax Expense
n/a n/a n/a 2K
Shares Outstanding (Basic)
27.03M 26.92M 22.51M 8.87M
Shares Outstanding (Diluted)
27.03M 26.92M 22.51M 8.92M
EPS (Basic)
-2.36 -2.44 -2.69 -12.41
EPS (Diluted)
-2.36 -2.44 -2.69 -12.41
EBITDA
-64.63M -71.76M -58.8M -36.96M
EBIT
-64.82M -71.93M -58.96M -37.06M
Depreciation & Amortization
193K 169K 159K 105K